Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression

EMBO Molecular Medicine

Volumn 6, Issue 3, 2014, Pages 322-334

  Chen, Chider ^a   Akiyama, Kentaro ^b   Yamaza, Takayoshi ^c   You, Yong Ouk ^a   Xu, Xingtian ^a   Li, Bei ^d   Zhao, Yimin ^d   Shi, Songtao ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Immunomodulation; Mesenchymal stem cell; Telomerase

Indexed keywords

ACETYLSALICYLIC ACID; BETA CATENIN; BRG1 PROTEIN; FAS LIGAND; TELOMERASE REVERSE TRANSCRIPTASE; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL TYPE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MESENCHYMAL STEM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; UPREGULATION;

ADIPOGENESIS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BETA CATENIN; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DNA HELICASES; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTES; TELOMERASE; TRANSCRIPTION FACTORS;

EID: 84895728149     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201303000     Document Type: Article

References (39)

1. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822
2. Akiyama K, Chen C, Wang D, Xu X, Qu C, Yamaza T, Cai T, Chen W, Sun L, Shi S (2012) Mesenchymal stem cell-induced immunoregulation involves Fas Ligand/Fas-mediated T cell apoptosis. Cell Stem Cell 10: 544-555
3. Batten P, Sarathchandra P, Antoniw JW, Tay SS, Lowdell MW, Taylor PM, Yacoub MH (2006) Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng 12: 2263-2273
4. Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, Zwart P, Muller I, Schewe B, Skutella T, Fibbe WE et al (2009) Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 94: 173-184
5. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B (2006) Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7: 14
6. Chen X, Armstrong MA, Li G (2006) Mesenchymal stem cells in immunoregulation. Immunol Cell Biol 84: 413-421
7. Chen XD, Qian HY, Neff L, Satomura K, Horowitz MC (1999) Thy-1 antigen expression by cells in the osteoblast lineage. J Bone Miner Res 14: 362-375
8. Choi J, Southworth LK, Sarin KY, Venteicher AS, Ma W, Chang W, Cheung P, Jun S, Artandi MK, Shah N et al (2008) TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet 4: e10
9. Deng L, Hu S, Baydoun AR, Chen J, Chen X, Cong X (2009) Aspirin induces apoptosis in mesenchymal stem cells requiring Wnt/beta-catenin pathway. Cell Prolif 42: 721-730
10. Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17: 984-992
11. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV (1974) Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17: 331-340
12. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC (2007) SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109: 1743-1751
13. Gronthos S, Chen S, Wang CY, Robey PG, Shi S (2003) Telomerase accelerates ostoegenesis of bone marrow stromal stem cells by upregulation of CBFA1, osterix, and osteocalcin. J Bone Miner Res 18: 716-722
14. Kwan MD, Slater BJ, Wan DC, Longaker MT (2008) Cell-based therapies for skeletal regenerative medicine. Hum Mol Genet 17: R93-R98
15. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441
16. Liang J, Gu F, Wnag H, Hua B, Hou Y, Shi S, Lu L, Sun L (2010) Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE. Nat Rev Rheumatol 6: 486-489
17. Liang J, Li X, Zhang H, Wang D, Feng X, Wang H, Hua B, Liu B, Sun L (2012) Allogenic mesenchymal stem cells transplantation in patients with refactory RA. Clin Rheumatol 31: 157-161
18. Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z, Sun L (2009) Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler 15: 644-646
19. Liu J, Han D, Wang Z, Xue M, Zhu L, Yan H, Zheng X, Guo Z, Wang H (2013) Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells. Cytotherapy 15: 185-191
20. Liu Y, Wang L, Likuiri T, Akiyama K, Chen C, Xu X, Yang R, Chen W, Wang S, Shi S (2011) Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nat Med 17: 1594-1601
21. Maser RS, DePinho RA (2002) Connecting chromosomes, crisis, and cancer. Science 26: 565-569
22. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase-mediated tryptophan degradation. Blood 103: 4619-4621
23. Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506
24. Panetta NJ, Gupta DM, Quarto N, Longaker MT (2009) Mesenchymal cells for skeletal tissue engineering. Panminerva Med 51: 25-41
25. Park J, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, Chang W, Meng Z, Cheung P, Ji H et al (2009) Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460: 66-72
26. Park MJ, Park HS, Cho ML, Oh HJ, Cho YG, Min SY, Chung BH, Lee JW, Kim HY, Cho SG (2011) Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis. Arthritis Rheum 63: 1668-1680
27. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74
28. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberta AI, Zhao RC, Shi Y (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2: 141-150
29. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K, Ozawa K (2007) Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109: 228-234
30. Scuderi N, Ceccarelli S, Onesti MG, Fioramonti P, Guidi C, Romano F, Frati L, Angeloni A, Marchese C (2013) Human adipose-derived stem cells for cell-based therapies in the treatment of systemic sclerosis. Cell Transplant 22: 779-795
31. Shi S, Gronthos S, Chen S, Reddi A, Counter CM, Robey PG, Wang CY (2002) Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 20: 587-591
32. Smogorzewska A, de Lange T (2004) Regulation of telomerase by telomeric proteins. Annu Rev Biochem 73: 177-208
33. Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S (2009) Mesenchymal stem cell transplantation reverses multi-organ dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27: 1421-1432
34. Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726-736
35. Uccelli A, Pistoia V, Moretta L (2007) Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 28: 219-226
36. Wang D, Akiyama K, Zhang H, Yamaza T, Li X, Feng X, Wang H, Hua B, Liu B, Xu H et al (2012) Double allogenic mesenchymal stem cells transplantations could not enhance therapeutic effect compared with single transplantation in systemic lupus erythematosus. Clin Dev Immunol 2012: 273291
37. Wang Y, Chen X, Zhu W, Zhang H, Hu S, Cong X (2006) Growth inhibition of mesenchymal stem cells by aspirin: involvement of the Wnt/beta-catenin signal pathway. Clin Exp Pharmacol Physiol 33: 696-701
38. Yamaza T, Miura Y, Bi Y, Liu Y, Akiyama K, Sonoyama W, Patel V, Gutkind S, Young M, Gronths S et al (2008) Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS ONE 3: e2615
39. Zhang Y, Xu G, Zhang L, Roberts AI, Shi Y (2008) Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma. J Immunol 181: 190-196